IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis.

Source:http://linkedlifedata.com/resource/pubmed/id/14561703

Download in:

View as

General Info

PMID
14561703